The Meharry-Vanderbilt-Tennessee State Cancer Partnership (MVTCP) recently hosted its 23rd Annual Symposium on February 10, 2024, showcasing innovative cancer research and fostering collaboration among primary investigators (PIs) and research students. The MVTCP is the longest running cancer research collaboration between three institutions, to date. The symposium boasted an impressive lineup of speakers, including the distinguished
Cristen Flewellen, a second-year Meharry medical student, was awarded Third Place in the Community Research category at the 67th Annual Meharry Student Research Day for her work with the Breast cancer Risk Assessment- achieVing Equity (BRAVE) study funded through the Meharry Vanderbilt Tennessee State Cancer Partnership (MVTCP). The BRAVE study PIs are Lucy Spalluto, MD
The meeting theme: “Building on a Solid Foundation to Strategically Strengthen and Enhance PACHE.” The gathering brought together PACHE (U54/P20) investigators, Program Managers, and NCI/CRCHD staff to discuss progress made by the program as well as topics that are important for the continued growth of PACHE. Photo of MVTCP Leadership: C. Whitted(MVA), L. Stewart(MMC), A.
